Research showed that people birthing in facilities with both midwives and doctors on staff were less likely to be induced, less likely to have their labor augmented with pitocin, less likely to have a cesarean, and more likely to have a successful vaginal birth after cesarean.
Neel Shah, MD, MMP shares his thoughts on the ARRIVE Trial. Dr. Shah is recognized as an innovative leader in maternal-infant health and a well-respected expert on effective methods for reducing the cesarean rate in the U.S.
Henci Goer examines the just-released ARRIVE Trial to determine if there is new information compared to the study abstract that raises more questions or answers the old ones? What should birth professionals understand and share with consumers about the evidence to induce at 39 weeks?
The California Health Care Foundation (CHCF), California Maternal Quality Care Collaborative (CMQCC), and Consumer Reports have partnered to develop and launch My Birth Matters, an educational campaign aimed at informing expectant parents about cesarean delivery.
Cesarean surgery is the most common inpatient surgical procedure in Canada, similar to the United States. 28.2% of all Canadian births were cesarean births in 2016-2017.